Significant drug interaction: Phenytoin toxicity due to erlotinib

被引:27
作者
Grenader, Tal [1 ]
Gipps, Maya [1 ]
Shavit, Linda [2 ]
Gabizon, Alberto [1 ]
机构
[1] Shaare Zedek Med Ctr, Dept Oncol, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Dept Med, IL-91031 Jerusalem, Israel
关键词
non-small cell lung cancer; erlotinib; phenytoin; drug interaction;
D O I
10.1016/j.lungcan.2007.02.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Brain metastases are a frequent finding in patients with advanced non-small cell lung cancer and concomitant administration of antiepileptic and chemotherapeutic drugs or epidermal growth factor receptor (EGFR) inhibitor is necessary in many cases. Anticonvulsants have clinically significant interactions with other drugs used in brain tumor patients. We report a case in which a potential drug interaction resulted in elevated phenytoin levels after initiation of erlotinib therapy in a patient who was receiving phenytoin. (c) 2007 Elsevier Iretand Ltd. All rights reserved.
引用
收藏
页码:404 / 406
页数:3
相关论文
共 7 条
[1]
Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports [J].
Brickell, K ;
Porter, D ;
Thompson, P .
BRITISH JOURNAL OF CANCER, 2003, 89 (04) :615-616
[2]
Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity [J].
Chiu, CH ;
Tsai, CM ;
Chen, YM ;
Chiang, SC ;
Liou, JL ;
Perng, RP .
LUNG CANCER, 2005, 47 (01) :129-138
[3]
Complete response to erlotinib treatment in brain metastases from recurrent NSCLC [J].
Lai, CSL ;
Boshoff, C ;
Falzon, M ;
Lee, SM .
THORAX, 2006, 61 (01) :91-91
[4]
Erlotinib in previously treated non-small-cell lung cancer [J].
Shepherd, FA ;
Pereira, JR ;
Ciuleanu, T ;
Tan, EH ;
Hirsh, V ;
Thongprasert, S ;
Campos, D ;
Maoleekoonpiroj, S ;
Smylie, M ;
Martins, R ;
van Kooten, M ;
Dediu, M ;
Findlay, B ;
Tu, DS ;
Johnston, D ;
Bezjak, A ;
Clark, G ;
Santabárbara, P ;
Seymour, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132
[5]
Interactions between antiepileptic and chemotherapeutic drugs [J].
Vecht, CJ ;
Wagner, GL ;
Wilms, EB .
LANCET NEUROLOGY, 2003, 2 (07) :404-409
[6]
Wakisaka S, 1990, Fukuoka Igaku Zasshi, V81, P192
[7]
2004, PROD INFO TARCEVA